Global Research Antibodies Market Expected to Grow with a CAGR of 6.2% During the Forecast Period, 2020-2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Research Antibodies Market Size, Share & Trends Analysis Report by Type (Monoclonal, Polyclonal), by End Use, by Product, by Technology, by Source, by Application (Oncology, Stem Cells), and Segment Forecasts, 2020 – 2027” report has been added to ResearchAndMarkets.com’s offering.

The global research antibodies market size is expected to reach USD 5.6 billion by 2027, exhibiting a CAGR of 6.2% over the forecast period according to this report.

Major market drivers include rise in R&D initiatives undertaken by biopharmaceutical and biotechnology companies and government bodies, growing interest in the study of neurobiology and stem cell, availability of technologically advanced products, and strategic collaborations among various market players and academic research organizations.

Designer antibodies are also anticipated to attract the attention of various academic organizations for their use in the R&D of novel products. For instance, in April 2019, scientists from ALS Canada Research Program developed a set of antibodies that can help in the detection of misfolded TDP-43 in various lab experiments that utilize post-mortem brain tissues. Rising usage of research antibodies for the development of novel diagnostic therapies is thus anticipated to fuel market growth in the near future.

Increase in the usage of research antibodies to develop treatment options for various diseases is also expected to boost market growth during the forecast period. For instance, in June 2019, the Institute of Life Sciences (ILS, India) developed antibodies against chikungunya viral infection. These antibody structures were developed to aid in the understanding of various aspects of virus pathogenesis, entailing further research on antiviral therapies. Growing government funds and initiatives for R&D is anticipated to fuel the Asia Pacific market during the forecast period. According to the 2018-2019 Australian Budget, approximately USD 94 million was estimated for four years for new industry collaborations, research as well as new biomedical and medical programs.

Additionally, rise in funds invested by pharmaceutical and biotechnology companies to enhance the study of proteomics and genomics is expected to drive the market. For instance, in 2017, Biognosys Inc. raised USD 5 million in funds to increase, advance, and develop next-generation proteomics products and workflow for high throughput and high content protein analysis. Rise in the number of major market players investing in advanced technologies and collaborating with other market players is also anticipated to positively impact market potential in the near future. For instance, Abcellera uses technologically advanced techniques to test antibodies from single B cells, map and screen natural immune responses, and to discover novel antibody therapies. The company has also partnered with Sanofi, Pfizer, Teva, Merck, and GSK to discover and develop new antibody-based therapies.

North America dominated the research antibodies market in owing to increasing focus on R&D in the fields of biomedicine, stem cell, and cancer. Rising prevalence of chronic diseases such as cardiovascular and blood diseases is also expected to fuel market growth.

Further key findings from the report suggest:

• By product, primary antibodies held the dominant share in 2019 in terms of revenue owing to greater specificity, therefore leading to increased adoption in R&D activities
• Based on type, monoclonal antibodies captured a substantial market share in 2019 as they offer higher sensitivity for detection of antigens and also showcase efficient staining properties for various applications
• The Western blotting technology segment has witnessed exponential growth owing to increasing prevalence of diseases with limited treatment options and rise in R&D activities conducted by pharmaceutical and biotechnology companies and academic institutes
• Based on end use, pharmaceutical and biotechnology companies were dominant in terms of revenue in 2019 owing to increased adoption of research antibodies in drug development and discovery
• North America accounted for a substantial share of the research antibodies market in 2019, which is attributable to high presence of many biotechnologies as well as biopharmaceutical manufacturers, research academies, and laboratories.

Key Topics Covered:

Chapter 1 Methodology and Scope

1.1 Market segmentation & scope

1.2 Market definition

1.3 Information procurement

1.4 Information analysis

1.5 Market formulation & data visualization

1.6 Data validation & publishing

Chapter 2 Executive Summary

2.1 Market Outlook

2.2 Segment Outlook

2.3 Competitive Insights

Chapter 3 Research Antibodies Market Variables, Trends & Scope

3.1 Market Lineage Outlook

3.2 Penetration And Growth Prospect Mapping

3.3 Regulatory Framework

3.4 Market Dynamics

3.5 Research Antibodies Market Analysis Tools

Chapter 4 Research Antibodies Market – Competitive Analysis

4.1 Recent Developments & Impact Analysis, By Key Market Participants

4.2 Company Categorization

4.3 Public Companies

4.4 Private Companies

Chapter 5 Research Antibodies Market: Product Estimates And Trend Analysis

5.1 Definition & Scope

5.2 Product Market Share Analysis, 2019 & 2027

5.3 Segment Dashboard

5.4 Global Research Antibodies Market, By Product, 2016 To 2027

5.5 Market Size & Forecasts And Trend Analyses, 2016 To 2027

5.6 Primary Antibodies

5.7 Secondary Antibodies

Chapter 6 Research Antibodies Market: Type Estimates And Trend Analysis

6.1 Definition & Scope

6.2 Type Market Share Analysis, 2019 & 2027

6.3 Segment Dashboard

6.4 Global Research Antibodies Market, By Type, 2016 To 2027

6.5 Market Size & Forecasts And Trend Analyses, 2016 To 2027

6.6 Monoclonal Antibodies

6.7 Polyclonal Antibodies

Chapter 7 Research Antibodies Market: Technology Estimates And Trend Analysis

7.1 Definition & Scope

7.2 Technology Market Share Analysis, 2019 & 2027

7.3 Segment Dashboard

7.4 Global Research Antibodies Market, By Technology, 2016 To 2027

7.5 Market Size & Forecasts And Trend Analyses, 2016 To 2027

7.6 Immunochemistry

7.7 Immunofluorescence

7.8 Western Blotting

7.9 Flow Cytometry

7.10 Immunoprecipitation

7.11 Elisa

7.12 Other Technologies

Chapter 8 Research Antibodies Market: Application Estimates And Trend Analysis

8.1 Definition & Scope

8.2 Application Market Share Analysis, 2019 & 2027

8.3 Segment Dashboard

8.4 Global Research Antibodies Market, By Application, 2016 To 2027

8.5 Market Size & Forecasts And Trend Analyses, 2016 To 2027

8.6 Infectious Diseases

8.7 Immunology

8.8 Oncology

8.9 Stem Cells

8.10 Neurobiology

8.11 Other Applications

Chapter 9 Research Antibodies Market: Source Estimates And Trend Analysis

9.1 Definition & Scope

9.2 Source Market Share Analysis, 2019 & 2027

9.3 Segment Dashboard

9.4 Global Research Antibodies Market, By Source, 2016 To 2027

9.5 Market Size & Forecasts And Trend Analyses, 2016 To 2027

9.6 Mouse Antibodies

9.7 Rabbit Antibodies

9.8 Goat Antibodies

9.9 Other Sources

Chapter 10 Research Antibodies Market: End Use Estimates And Trend Analysis

10.1 Definition & Scope

10.2 End Use Market Share Analysis, 2019 & 2027

10.3 Segment Dashboard

10.4 Global Research Antibodies Market, By End Use, 2016 To 2027

10.5 Market Size & Forecasts And Trend Analyses, 2016 To 2027

10.6 Academic & Research Institutes

10.7 Contract Research Organizations

10.8 Pharmaceutical & Biotechnology Companies

Chapter 11 Research Antibodies Market: Regional Estimates & Trend Analysis

11.1 Regional Market Snapshot

11.2 Market Share Analysis By Country, 2019

11.3 SWOT Analysis, By Factor

11.4 Market Size & Forecasts, And Trend Analysis, 2019 To 2026

11.4.1 North America

11.4.2 Europe

11.4.3 Asia Pacific

11.4.4 Latin America

11.4.5 Middle East & Africa

Chapter 12 Company Profiles

12.1 Company Profiles

12.1.1 Abcam Plc

12.1.2 Bio – Rad Laboratories

12.1.3 BD

12.1.4 Merck Millipore

12.1.5 Lonza Group

12.1.6 Thermo Fisher Scientific

12.1.7 Cell Signalling Technology, Inc.

12.1.8 F.Hoffmann La Roche Ltd.

12.1.9 Agilent Technologies

12.1.10 Perkinelmer, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/3ntxtx

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900